Great Point Partners LLC Acumen Pharmaceuticals, Inc. Transaction History

Great Point Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.15 - $9.72 $94,761 - $221,946	22,834 Added 2.17%	1,074,101 $4.46 Million
Q1 2023 May 15, 2023	SELL	$3.75 - $6.65 $244,927 - $434,338	-65,314 Reduced 5.85%	1,051,267 $4.27 Million
Q4 2022 Feb 14, 2023	SELL	$4.81 - $10.17 $401,245 - $848,371	-83,419 Reduced 6.95%	1,116,581 $6.03 Million
Q3 2022 Nov 14, 2022	SELL	$4.44 - $10.48 $1.4 Million - $3.3 Million	-315,000 Reduced 20.79%	1,200,000 $12 Million
Q2 2022 Aug 15, 2022	BUY	$3.08 - $4.88 $1.81 Million - $2.86 Million	586,718 Added 63.2%	1,515,000 $7.12 Million
Q1 2022 May 16, 2022	BUY	$3.91 - $6.73 $3.63 Million - $6.25 Million	928,282 New	928,282 $3.63 Million

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.5M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.